Abstract
Hyperuricemia is associated with all risk factors of Metabolic syndrome and is viewed as a biomarker and therapeutic target for cardiometabolic treatments. This comprehensive review examines the multifaceted landscape of hyperuricemia delving into its epidemiology, intricate pathophysiology, diverse associations with health conditions and contemporary approaches to its management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Hyperuricemia Unravelled: Elevated Uric Acid Levels and Its Implications on Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
